PhD Žiga Jakopin
no.: 26496

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy
3.01.00	Medical sciences	Microbiology and immunology

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

1,270.11

A''

300.98

A'

983.18

A1/2

1,089.02

CI10

1,204

CImax

122

h10

17

A1

4.98

A3

0.25

Data for the last 5 years (citations for the last 10 years) on April 27, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)

Data for ARIS tenders ( 12.01.2024 – Project tender, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	59	1,350	1,184	20.07
Scopus	60	1,450	1,274	21.23

Audiovisual sources

no.	Title (with video link)	Event	Source
1.

Mentoring junior researchers

source: ARIS

no.	Name and surname	Type	Period	Code
1	Veronika Weiss	Bologna doctoral studies	10/1/2020 - 9/30/2024	54787

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group
Full time employment (120%, RD:70%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	J3-4496	Next-generation adjuvants for mucosal vaccines	2022 - 2024	PhD Žiga Jakopin	1,196
2.	BI-RS/23-25-016	Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors	2023 - 2024	PhD Žiga Jakopin	195
3.	J1-3031	Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance	2021 - 2024	PhD Nace Zidar	1,033
4.	BI-US/22-24-182	Characterization of NOD2 receptor ligand binding	2022 - 2024	PhD Žiga Jakopin	195
5.	J3-2517	Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants	2020 - 2023	PhD Žiga Jakopin	2,206
6.	J1-2485	The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs	2020 - 2023	PhD Izidor Sosič	953
7.	J1-1717	Development of novel Hsp90 inhibitors with anticancer activity	2019 - 2023	PhD Tihomir Tomašić	1,894
8.	J3-9256	Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants	2018 - 2022	PhD Žiga Jakopin	2,805
9.	J1-8140	Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi	2017 - 2020	PhD Metka Filipič	3,739

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P1-0420	Advanced immunological drugs and cell-based approaches in pharmacy	2022 - 2024	PhD Žiga Jakopin	1,241
2.	I0-E011	Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta EATRIS (Slovene)	2022	PhD Irena Mlinarič Raščan	1,900
3.	I0-0022	Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)	2021	PhD Anton Ramšak	13,481
4.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	2015 - 2021	PhD Stanislav Gobec	5,977
5.	P1-0208	Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)	2009 - 2014	PhD Danijel Kikelj	5,850
6.	P1-0208	Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin (Slovene)	2006 - 2008	PhD Danijel Kikelj	6,007

International projects

no.	Code	Title	Period	Head	No. of publications
1.	COST-CA16231	European Network of Vaccine Adjuvants	11/13/2017 - 11/12/2021	Žiga Jakopin
2.	COST-CA15138	European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)	4/22/2016 - 4/21/2020	Žiga Jakopin

We were not given permission by the researcher to publish data.